Relationship of folate, vitamin B12 and methylation of insulin-like growth factor-II in maternal and cord blood.
OBJECTIVE
One of the speculated mechanisms underlying fetal origin hypothesis of breast cancer is the possible influence of maternal environment on epigenetic regulation, such as changes in DNA methylation of the insulin-like growth factor-2 (IGF2) gene. The aim of the study is to investigate the relationship between folate, vitamin B(12) and methylation of the IGF2 gene in maternal and cord blood.


METHODS
We conducted a cross-sectional study to measure methylation patterns of IGF2 in promoters 2 (P2) and promoters 3 (P3).


RESULTS
The percentage of methylation in IGF2 P3 was higher in maternal blood than in cord blood (P<0.0001), whereas the methylation in P2 was higher in cord blood than in maternal blood (P=0.016). P3 methylation was correlated between maternal and cord blood (P<0.0001), but not P2 (P=0.06). The multivariate linear regression model showed that methylation patterns of both promoters in cord blood were not associated with serum folate levels in either cord or maternal blood, whereas the P3 methylation patterns were associated with serum levels of vitamin B(12) in mother's blood (mean change (MC)=-0.22, P=0.0014). Methylation patterns in P2 of maternal blood were associated with serum levels of vitamin B(12) in mother's blood (MC=-0.23, P=0.012), exposure to passive smoking (MC=0.46, P=0.034) and mother's weight gain during pregnancy (MC=0.23, P=0.019).


CONCLUSIONS
The study suggests that environment influences methylation patterns in maternal blood, and then the maternal patterns influence the methylation status and levels of folate and vitamin B(12) in cord blood.
School of Public Health, Zhengzhou University, Zhengzhou, China.
Y
Y
Ba
H
H
Yu
F
F
Liu
X
X
Geng
C
C
Zhu
Q
Q
Zhu
T
T
Zheng
S
S
Ma
G
G
Wang
Z
Z
Li
Y
Y
Zhang
D000328:Adult; D001724:Birth Weight; D003430:Cross-Sectional Studies; D019175:DNA Methylation; D057890:Epigenomics; D005260:Female; D005312:Fetal Blood / Q000737:chemistry*; D005492:Folic Acid / Q000097:blood*; D006801:Humans; D007231:Infant, Newborn; D007335:Insulin-Like Growth Factor II / Q000378:metabolism*; D016014:Linear Models; D008297:Male; D010865:Pilot Projects; D011247:Pregnancy; D011401:Promoter Regions, Genetic; D014805:Vitamin B 12 / Q000097:blood*; D014803:Vitamin B Complex
D014803:Vitamin B Complex; D007335:Insulin-Like Growth Factor II; D005492:Folic Acid; D014805:Vitamin B 12
Lancet. 1990 Apr 21;335(8695):939-40
1970028
Endocrine. 2009 Apr;35(2):204-10
19199084
FEBS Lett. 1998 Oct 16;437(1-2):107-11
9804181
Am J Hum Genet. 2003 Jan;72(1):156-60
12439823
J Nutr. 2004 Sep;134(9):2169-72
15333699
Scand J Clin Lab Invest Suppl. 1995;220:37-46
7652480
J Cancer Res Clin Oncol. 2007 Oct;133(10):713-23
17569086
Mol Cell Endocrinol. 1991 Oct;81(1-3):81-94
1797589
J Clin Endocrinol Metab. 2000 Nov;85(11):4266-9
11095465
J Biol Chem. 1992 Sep 25;267(27):19404-11
1527060
Mol Cell Biol. 2003 Aug;23(15):5293-300
12861015
Br J Nutr. 2006 Mar;95(3):511-6
16512937
Cell Prolif. 1998 Oct-Dec;31(5-6):173-89
9925986
Mol Reprod Dev. 1993 Aug;35(4):391-3
8398117
Eur J Clin Nutr. 1989 Aug;43(8):505-13
2598892
J Nutr. 2005 Jun;135(6):1382-6
15930441
Proc Natl Acad Sci U S A. 1996 Oct 15;93(21):11757-62
8876210
Am J Hum Genet. 2002 Jul;71(1):162-4
12016591
Nature. 1997 Oct 23;389(6653):809-15
9349812
Hum Mol Genet. 1996 Aug;5(8):1123-7
8842730
FASEB J. 1998 Aug;12(11):949-57
9707167
Br J Cancer. 1995 Nov;72(5):1189-93
7577466
Am J Hum Genet. 2003 Jan;72(1):218-9
12549484
Int J Cancer. 2006 Nov 1;119(9):2007-25
16823839
Nat Rev Genet. 2001 Jan;2(1):21-32
11253064
Biochem Biophys Res Commun. 1997 Jun 9;235(1):123-9
9196048
Annu Rev Nutr. 2002;22:255-82
12055346
Int J Vitam Nutr Res. 1985;55(2):205-16
4019076